Akorn Inc. ( AKRX- Get Report ) shares plunged the most since February in pre-market trading Monday after Germany's Fresenius Medical Care ( FSNUY) dropped its planned $5 billion takeover of the generic drugmaker after a probe into possible data breaches by the U.S. Food & Drug Administration.
Akorn Plunges as Germany's Fresenius Ditches Takeover Amid Data Allegations
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться